Survival prostate cancer diagnostic imaging. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Neoplastic Cells, Circulating Rectum Cell Line Stromal Cells

Organisms5

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Transgenic Mice, Inbred C57BL

Diseases36

Neoplasms Prostatic Neoplasms Prostatic Hyperplasia Neoplasms, Hormone-Dependent Adenocarcinoma Neoplasm Metastasis Disease Progression Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Breast Neoplasms Lung Neoplasms Genetic Predisposition to Disease Neoplasm Recurrence, Local Carcinoma Ovarian Neoplasms Colonic Neoplasms Stomach Neoplasms Prostatic Neoplasms, Castration-Resistant Pancreatic Neoplasms Colorectal Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Disease Models, Animal Urinary Bladder Neoplasms Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Neovascularization, Pathologic Prostatitis Liver Neoplasms Uterine Cervical Neoplasms Lymphatic Metastasis Rectal Neoplasms Neoplastic Cells, Circulating Recurrence Esophageal Neoplasms

Chemicals and Drugs64

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Antineoplastic Agents Tosyl Compounds Neoplasm Proteins Antineoplastic Agents, Hormonal RNA, Messenger Androgen Receptor Antagonists Anilides Dihydrotestosterone Finasteride RNA, Small Interfering Metribolone Taxoids Cancer Vaccines Flutamide DNA, Neoplasm Anticarcinogenic Agents PTEN Phosphohydrolase Glutamate Carboxypeptidase II 5-alpha Reductase Inhibitors Antigens, Neoplasm Antineoplastic Agents, Phytogenic Tumor Suppressor Protein p53 Testosterone Congeners Nitriles Testosterone Transcription Factors Androstenols Antibodies, Monoclonal 3-Oxo-5-alpha-Steroid 4-Dehydrogenase MicroRNAs RNA, Neoplasm Phenylthiohydantoin Azasteroids Receptor, erbB-2 Tumor Suppressor Proteins Proto-Oncogene Proteins Proto-Oncogene Proteins c-akt DNA-Binding Proteins Racemases and Epimerases Receptors, Estrogen Estramustine DNA Primers Enzyme Inhibitors Cisplatin Leuprolide Paclitaxel Cholestenone 5 alpha-Reductase Goserelin Glutathione S-Transferase pi Fluorouracil Ki-67 Antigen Biological Markers Protein-Serine-Threonine Kinases Receptor, Epidermal Growth Factor Radiopharmaceuticals Nuclear Proteins Oncogene Proteins, Fusion Kallikreins Protein Kinase Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment83

Survival Rate Prostatectomy Disease-Free Survival Orchiectomy Survival Analysis Early Detection of Cancer Neoplasm Staging Prognosis Sensitivity and Specificity Retrospective Studies Treatment Outcome Neoplasm Grading Risk Factors Follow-Up Studies Reverse Transcriptase Polymerase Chain Reaction Prospective Studies Immunohistochemistry Xenograft Model Antitumor Assays Kaplan-Meier Estimate Predictive Value of Tests Neoplasm Transplantation Gene Expression Profiling Digital Rectal Examination Biopsy Blotting, Western Transplantation, Heterologous Case-Control Studies Risk Assessment Combined Modality Therapy Cohort Studies Antineoplastic Combined Chemotherapy Protocols Risk Reproducibility of Results Multivariate Analysis Biopsy, Needle Incidence Transurethral Resection of Prostate Registries Polymerase Chain Reaction Oligonucleotide Array Sequence Analysis Odds Ratio Proportional Hazards Models Tissue Array Analysis Tumor Burden Transfection SEER Program Brachytherapy Diagnostic Errors Diagnostic Imaging ROC Curve Radiotherapy Logistic Models Radiotherapy Dosage Castration Disease Models, Animal Nomograms Questionnaires Models, Biological Molecular Targeted Therapy Immunoenzyme Techniques Diagnostic Tests, Routine Clinical Trials as Topic Mass Screening Chemotherapy, Adjuvant Drug Screening Assays, Antitumor Radiotherapy, Conformal Diagnostic Techniques and Procedures Confidence Intervals Tomography, X-Ray Computed Gene Knockdown Techniques In Situ Hybridization, Fluorescence Enzyme-Linked Immunosorbent Assay Drug Administration Schedule Real-Time Polymerase Chain Reaction Flow Cytometry Magnetic Resonance Imaging Radiotherapy, Intensity-Modulated Immunotherapy Probability Positron-Emission Tomography Regression Analysis Genetic Therapy Radiotherapy Planning, Computer-Assisted

Psychiatry and Psychology1

Phenomena and Processes46

Cell Survival Gene Expression Regulation, Neoplastic Sensitivity and Specificity Apoptosis Cell Proliferation Time Factors Genetic Predisposition to Disease Signal Transduction Risk Drug Resistance, Neoplasm Genotype Graft Survival Cell Growth Processes Down-Regulation Cell Division Odds Ratio Mutation Cell Movement Transfection Up-Regulation Dose-Response Relationship, Drug DNA Methylation Cell Cycle Promoter Regions, Genetic Polymorphism, Genetic Nomograms RNA Interference Base Sequence Gene Silencing Gene Expression Phosphorylation Genes, Tumor Suppressor Gene Fusion Chromosomes, Human, Pair 8 Phenotype Polymorphism, Single Nucleotide Alleles Transcription, Genetic Diet Genes, Neoplasm Drug Synergism Probability Algorithms Radiation Tolerance Germ-Line Mutation Enzyme Activation

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

Survival National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science11

Survival Rate Incidence Registries SEER Program Molecular Sequence Data Questionnaires Base Sequence Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Algorithms Radiotherapy Planning, Computer-Assisted

Named Groups4

European Continental Ancestry Group African Americans Survivors African Continental Ancestry Group

Health Care36

Patient Navigation Survival Rate Disease-Free Survival Survival Analysis Sensitivity and Specificity Retrospective Studies Treatment Outcome Risk Factors Follow-Up Studies Prospective Studies Kaplan-Meier Estimate Predictive Value of Tests Case-Control Studies Watchful Waiting Risk Assessment Cohort Studies Risk Reproducibility of Results Multivariate Analysis Incidence Age Factors Registries Odds Ratio Proportional Hazards Models SEER Program Diagnostic Errors ROC Curve Logistic Models National Cancer Institute (U.S.)Nomograms Questionnaires Clinical Trials as Topic Mass Screening Confidence Intervals Probability Regression Analysis

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Patient Navigation Prostate Neoplasms Prostatic Neoplasms Prostate-Specific Antigen Survival Rate Cell Survival Cell Line, Tumor Receptors, Androgen Androgens Androgen Antagonists Prostatectomy Gene Expression Regulation, Neoplastic Prostatic Hyperplasia Disease-Free Survival Tumor Markers, Biological Orchiectomy Neoplasms, Hormone-Dependent Survival Analysis Adenocarcinoma Neoplasm Metastasis Disease Progression Early Detection of Cancer Neoplasm Staging Mice, Nude Prognosis Sensitivity and Specificity Apoptosis Retrospective Studies Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Cell Proliferation Antineoplastic Agents Treatment Outcome Neoplasm Grading Risk Factors Tosyl Compounds Follow-Up Studies Survival Breast Neoplasms Reverse Transcriptase Polymerase Chain Reaction Tumor Cells, Cultured Prospective Studies Neoplasm Proteins Immunohistochemistry Antineoplastic Agents, Hormonal Time Factors Lung Neoplasms Genetic Predisposition to Disease Xenograft Model Antitumor Assays RNA, Messenger Neoplasm Recurrence, Local Androgen Receptor Antagonists Signal Transduction Kaplan-Meier Estimate Predictive Value of Tests Neoplasm Transplantation Gene Expression Profiling Digital Rectal Examination Biopsy Carcinoma Blotting, Western Transplantation, Heterologous Case-Control Studies Anilides Watchful Waiting Risk Assessment Combined Modality Therapy Dihydrotestosterone Cohort Studies Ovarian Neoplasms Antineoplastic Combined Chemotherapy Protocols United States Risk Finasteride Reproducibility of Results Multivariate Analysis Drug Resistance, Neoplasm Biopsy, Needle RNA, Small Interfering Genotype Graft Survival Incidence Cell Growth Processes Down-Regulation Cell Division Age Factors Transurethral Resection of Prostate Metribolone Colonic Neoplasms Taxoids Stomach Neoplasms Mice, SCID Registries Prostatic Neoplasms, Castration-Resistant Cancer Vaccines Flutamide Polymerase Chain Reaction Oligonucleotide Array Sequence Analysis

No FAQ available that match "survival prostate cancer diagnostic imaging"